Cellular Antioxidant Defense
Represents the next frontier in obesity pharmacotherapy, targeting multiple hormonal pathways
doi:10.1093/ajcn/77.1.189 Rafighi Z, Shiva A, Arab S, Mohd Yousof R
Newer injectable peptides sold through the "grey market" FDA approval for peptides, such as insulin and GLP1s, ensures oversight of how these medications are manufactured and distributed
Regulatory approval requires extensive human testing to establish safety, dosing, and therapeutic benefit
Pregnant or Nursing Women While GHK-Cu is generally suitable for topical use, consult a healthcare professional before use during pregnancy or breastfeeding